0001181431-12-059387.txt : 20121119 0001181431-12-059387.hdr.sgml : 20121119 20121119162138 ACCESSION NUMBER: 0001181431-12-059387 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121115 FILED AS OF DATE: 20121119 DATE AS OF CHANGE: 20121119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bancel Stephane CENTRAL INDEX KEY: 0001443340 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33827 FILM NUMBER: 121214834 MAIL ADDRESS: STREET 1: CHEMIN DE L'ORME CITY: MARCY L'ETOILE STATE: I0 ZIP: 69280 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BG Medicine, Inc. CENTRAL INDEX KEY: 0001407038 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 043506204 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 610N LINCOLN STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-890-1199 MAIL ADDRESS: STREET 1: 610N LINCOLN STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 rrd360769.xml FORM 4 - STEPHANE BANCEL X0306 4 2012-11-15 0 0001407038 BG Medicine, Inc. BGMD 0001443340 Bancel Stephane C/O BG MEDICINE, INC. 610 LINCOLN STREET NORTH WALTHAM MA 02451 1 1 0 0 Executive Chairman Common Stock 2012-11-15 4 P 0 100000 1.26 A 123167 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.17 to $1.35, inclusive. The reporting person undertakes to provide to BG Medicine, Inc., any security holder of BG Medicine, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. /s/ Linda Rockett, Attorney-in-fact 2012-11-19